Patent Foramen Ovale and Cryptogenic Stroke: Integrated Management-Reference-Cited by-同舟云学术

Patent Foramen Ovale and Cryptogenic Stroke: Integrated Management

Published:2023-03-01 Issue:5 Volume:12 Page:1952
ISSN:2077-0383
Container-title:Journal of Clinical Medicine
language:en
Short-container-title:JCM

Author:

Lucà Fabiana¹^ORCID,Pino Paolo G.²,Parrini Iris³^ORCID,Di Fusco Stefania Angela⁴^ORCID,Ceravolo Roberto⁵,Madeo Andrea⁶,Leone Angelo⁷,La Mair Mark⁸^ORCID,Benedetto Francesco Antonio¹,Riccio Carmine⁹,Oliva Fabrizio¹⁰,Colivicchi Furio⁴^ORCID,Gulizia Michele Massimo¹¹,Gelsomino Sandro¹²^ORCID

Affiliation:

1. Cardiology Department, Grande Ospedale Metropolitano, GOM, AO Bianchi Melacrino Morelli, 89129 Reggio di Calabria, Italy

2. Cardiology Department, San Camillo Forlanini Hospital, 00152 Rome, Italy

3. Cardiology Department, Mauriziano Hospital, 10128 Torino, Italy

4. Clinical and Rehabilitation Cardiology Department, San Filippo Neri Hospital, ASL Roma 1, 00135 Roma, Italy

5. Cardiology Unit, Giovanni Paolo II Hospital, 88046 Lamezia, Italy

6. Ferrari Hospital, 87012 Castrovillari, Italy

7. Ospedale Santissima Annunziata, 87100 Cosenza, Italy

8. Cardiothoracic Department, Brussels University Hospital, 1090 Jette, Belgium

9. Division of Clinical Cardiology, A.O.R.N. ‘Sant’Anna e San Sebastiano’, 81100 Caserta, Italy

10. De Gasperis Cardio Center, Niguarda Hospital, 20162 Milano, Italy

11. Cardiothoracic Department, Garibaldi Nesima Hospital, 95122 Catania, Italy

12. Cardiothoracic Department, Maastricht University, 6211 LK Maastrich, The Netherlands

Abstract

Patent foramen ovale (PFO) is a common cardiac abnormality with a prevalence of 25% in the general population. PFO has been associated with the paradoxical embolism causing cryptogenic stroke and systemic embolization. Results from clinical trials, meta-analyses, and position papers support percutaneous PFO device closure (PPFOC), especially if interatrial septal aneurysms coexist and in the presence of large shunts in young patients. Remarkably, accurately evaluating patients to refer to the closure strategy is extremely important. However, the selection of patients for PFO closure is still not so clear. The aim of this review is to update and clarify which patients should be considered for closure treatment.

Publisher

MDPI AG

Subject

General Medicine

Link

https://www.mdpi.com/2077-0383/12/5/1952/pdf

Reference127 articles.

1. Patent foramen ovale: Going beyond the bubbles;Zoghbi;JACC Cardiovasc. Imaging,2014

2. Prevalence of patent foramen ovale in patients with stroke;Lechat;N. Engl. J. Med.,1988

3. Doing a Deep Dive on Patent Foramen Ovale: Stay Tuned in the PFO World;Orsinelli;JACC Cardiovasc. Imaging,2022

4. Migraine in Patients Undergoing PFO Closure: Characterization of a Platelet-Associated Pathophysiological Mechanism: The LEARNER Study;Trabattoni;JACC Basic Transl. Sci.,2022

5. Platypnea-Orthodeoxia Syndrome in the Setting of Patent Foramen Ovale Without Pulmonary Hypertension or Major Lung Disease;Othman;J. Am. Heart Assoc.,2022

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Not just any headache;Survey of Ophthalmology;2023-10

2. The predictive value of abnormal electrocardiogram for patent foramen ovale: A retrospective study;Clinical Cardiology;2023-09-04

3. Modified Risk of Paradoxical Embolism More Effectively Evaluates the Risk of Stroke Associated with Patent Foramen Ovale;Current Neurovascular Research;2023-08